Medtronic (MDT) ended the recent trading session at $83.87, demonstrating a +1.8% change from the preceding day's closing ...

Medtronic stock is a "Buy" given its premium-margin medtech, diversification, accelerated growth, and undervalued shares.

Medtronic delivered $36.4B in revenue, the strongest growth in a decade, led by Cardiovascular and ablation solutions. Learn ...

Medtronic stock sits in an interesting middle ground, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing ...

It has been about a month since the last earnings report for Medtronic (MDT). Shares have added about 1.5% in that time frame, outperforming the S&P 500. Will the recent positive trend continue ...

Medtronic recently reported strong results, highlighting impressive growth.

Citi analyst Joanne Wuensch reiterated a Buy rating on Medtronic on July 6 and set a price target of $110.00. The company’s shares closed yesterday at $83.06. 55% Off TipRanks.

Medtronic (NYSE: MDT) is a medical device company with vast and diverse operations. Its business is fairly stable although the stock's returns haven't been all that great. However, it also provides ...

Shares of Medtronic PLC MDT shed 3.34% to $78.23 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 7,499.36 and the ...

For years, investors questioned whether Medtronic was moving quickly and innovating enough. Now, the company is answering ...

Investing in healthcare hasn't been all that exciting an option for investors in recent years. But over the long term, it can lead to significant returns. Healthcare is not only essential but a ...